Long term impact of formula choice in children with cow milk protein allergy: 6-year follow-up of the Atopic March Cohort Study
Clinical Nutrition · 2025
DOI: 10.1016/j.clnu.2025.03.026 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Clinical Nutrition, 2025. Verfasst von Rita Nocerino und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational Medical Science, University of Naples "Federico II", Naples, Italy; ImmunoNutritionLab at CEINGE Advanced Biotechnologies…. Hauptthemen laut MEDLINE: Milk Hypersensitivity, Infant Formula, Milk Proteins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell’Istruzione, dell’Università e della Ricerca, Mead Johnson Nutrition, European Commission.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
BACKGROUND AND AIMS: Cow's milk protein allergy (CMPA) is a significant health issue in the pediatric age, carrying lifelong health implications. To compare the impact of different formulas on the occurrence of other atopic manifestations (AMs), autoimmune disorders (ADs) and the time of immune tolerance acquisition in a population of children with immunoglobulin E (IgE)-mediated cow CMPA. METHODS: In a 72-month prospective cohort study the occurrence of other AMs (i.e., eczema, urticaria, asthma, and rhinoconjunctivitis), ADs (i.e., celiac disease, thyroiditis, type 1 diabetes, inflammatory bowel diseases, idiopathic juvenile arthritis) and the time of immune tolerance acquisition were comparatively evaluated in IgE-mediated CMPA children treated with different formulas: extensively hydrolyzed casein formula containing the probiotic L. rhamnosus G (EHCF + LGG), rice hydrolyzed formula (RHF), soy formula (SF), extensively hydrolyzed whey formula (EHWF), or amino-acid based formula (AAF). RESULTS: 313 subjects were evaluated: EHCF + LGG (n = 64), RHF(n = 62), SF(n = 63), EHWF(n = 60) and AAF (n = 64). The incidence of AMs was: 0.30(Bonferroni-corrected 95%CI 0.15 to 0.44) for EHCF + LGG cohort, 0.68 (0.52-0.83) for RHF cohort, 0.73 (0.59-0.87) for SF cohort, 0.70 (0.55-0.85) for EHWF cohort and 0.83 (0.71-0.95) for AAF cohort. The corresponding risk ratios are 2.28 (1.51-3.45) for RHF vs. EHCF + LGG (p < 0.001), 2.46 (1.64-3.69) for SF vs. EHCF + LGG (p < 0.001), 2.36 (1.56-3.56) for EHWF vs. EHCF + LGG (p < 0.001), and 2.79 (1.88-4.13) for AAF vs. EHCF + LGG (p < 0.001). The 72-month immune tolerance acquisition rate was higher in the EHCF + LGG cohort. The incidence of celiac disease was 2/313 (0.006, binomial exact 95%CI 0.0007 to 0.023). No cases of other ADs were reported. CONCLUSION: The dietary treatment with EHCF + LGG is associated with lower incidence of AMs and higher rate of immune tolerance acquisition in children with CMPA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Translational Medical Science, University of Naples "Federico II", Naples, Italy; ImmunoNutritionLab at CEINGE Advanced Biotechnologies, University of Naples "Federico II", Naples, Italy; Department of Bio…
- Department of Medical and Surgical Sciences, Alma Mater Studiorum-University of Bologna, Bologna, Italy; Department of Primary Health Care, Internal Medicine Unit addressed to Frailty and Aging, "S. Maria delle Croci" H…
- Department of Translational Medical Science, University of Naples "Federico II", Naples, Italy; ImmunoNutritionLab at CEINGE Advanced Biotechnologies, University of Naples "Federico II", Naples, Italy.
- Department of Translational Medical Science, University of Naples "Federico II", Naples, Italy.
- Department of Translational Medical Science, University of Naples "Federico II", Naples, Italy; ImmunoNutritionLab at CEINGE Advanced Biotechnologies, University of Naples "Federico II", Naples, Italy; European Laborato…
Förderung
- Ministero dell’Istruzione, dell’Università e della Ricerca
- Mead Johnson Nutrition
- European Commission
- Ministero della Salute
- Università degli Studi di Napoli Federico II
Zitieren
APA
Nocerino, R., Bedogni, G., Carucci, L., Aquilone, G., Oglio, F., Coppola, S., Masino, A., & Berni Canani, R. (2025). Long term impact of formula choice in children with cow milk protein allergy: 6-year follow-up of the Atopic March Cohort Study. Clinical Nutrition. https://doi.org/10.1016/j.clnu.2025.03.026
Vancouver
Nocerino R, Bedogni G, Carucci L, Aquilone G, Oglio F, Coppola S, et al. Long term impact of formula choice in children with cow milk protein allergy: 6-year follow-up of the Atopic March Cohort Study. Clinical Nutrition. 2025. doi:10.1016/j.clnu.2025.03.026
BibTeX
@article{Nocerino2025,
author = {Nocerino, Rita and Bedogni, Giorgio and Carucci, Laura and Aquilone, Greta and Oglio, Franca and Coppola, Serena and Masino, Antonio and Berni Canani, Roberto},
title = {Long term impact of formula choice in children with cow milk protein allergy: 6-year follow-up of the Atopic March Cohort Study},
journal = {Clinical Nutrition},
year = {2025},
doi = {10.1016/j.clnu.2025.03.026}
}
EUVIMED